Sort
10,766 grants matching “checkpoint inhibitor”
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$603,529Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$603,069David G Denardo · Washington University · R01 · FY2023 · CA
Novel immunotherapies using optimized tumor cell-penetrating antibodies
$602,881Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
Regulation of Mitotic Kinetochores by the Ran GTPase
$602,846Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$602,783Timothy R Donahue · University Of California Los Angeles · R01 · FY2022 · CA
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$602,576Kian H Lim · Washington University · R01 · FY2025 · CA
The NOTCH Signaling Pathway in Large Vessel Vasculitis
$602,096Cornelia M Weyand · Mayo Clinic Rochester · R01 · FY2024 · HL
High-content functional cancer drug testing on micro-cuboidal tumor dissections
$601,999Albert Folch · University Of Washington · R21 · FY2020 · CA
Guarding the Genome: Aneuploidy and tumorigenesis
$601,980Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2016 · GM
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression
$601,947Heide L Ford · University Of Colorado Denver · R01 · FY2019 · CA
Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
$601,312Hong Chen · Washington University · R01 · FY2024 · EB
Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment
$601,253Yubin Miao · University Of Colorado Denver · R01 · FY2024 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$601,230Elias Sayour · University Of Florida · R37 · FY2024 · CA
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$600,913Efstathios Karathanasis · Case Western Reserve University · R01 · FY2023 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$600,798Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$599,837Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2021 · NS
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2018 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2019 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · OD
Engineering immunotherapeutic probiotics to mitigate irAE
$599,683Tal Danino · Columbia Univ New York Morningside · U01 · FY2023 · CA
Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study
$599,442Rebecca Ashare · State University Of New York At Buffalo · U01 · FY2024 · CA
Immune Checkpoints in Acute Respiratory Distress Syndrome (IC-ARDS)
$599,398Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · HL
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$599,301Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2023 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$599,281Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$599,074Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA